Dr. Craig B. Langman MD

Expert Publications

• Think of genetic hypercalciuria when a child has urinary tract findings.
• Immunoradiometric assay for intact human osteocalcin(1-49) without cross-reactivity to breakdown products.
• Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
• Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria.
• New developments in calcium and vitamin D metabolism.
• Persistent hypoparathyroidism following magnesium repletion in burn-injured children.
• The optimal approach to the patient with oxalosis.
• Hepatic osteodystrophy in chronic cholestasis: evidence for a multifactorial etiology.
• Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos.
• Improvement of bone in patients with osteogenesis imperfecta treated with pamidronate-lessons from biochemistry.
• L-carnitine treatment of anemia.
• A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria.
• The molecular basis of kidney stones.
• Genetic regulation of bone mass: from bone density to bone strength.
• Population based data on urinary excretion of calcium, magnesium, oxalate, phosphate and uric acid in children from Cimitile (southern Italy).

Clinical Trials

• Prospective Research Rare Kidney Stones (ProRKS)

Media Releases

Get to know Pediatric Nephrologist Dr. Craig B. Langman, who serves patients in Chicago, Illinois.

Dr. Langman, a seasoned pediatric nephrologist and can be found on staff at Northwestern Memorial Hospital.

His areas of clinical focus include rare genetic kidney diseases, osteoporosis in children, inherited and acquired bone disease in children, disorders of calcification, disorders of phosphorus metabolism, and chronic kidney diseases of childhood.

Holding academic appointments, Dr. Langman is the first Isaac A. Abt, MD, Professor of Kidney Diseases, Emeritus and Tenured Professor of Pediatrics at the Feinberg School of Medicine at Northwestern University.

His funded research focuses on the basic and clinical expression of inherited or acquired disorders of calcium, phosphorus vitamin D, and FGF23 metabolism, mechanisms of cardiovascular diseases in children with obesity or chronic kidney disease, pediatric hypertension, inherited genetic diseases (cystinosis, oxalosis, kidney stones, atypical HUS, hypophosphatasia), and the rehabilitation of patients around the world with chronic kidney disease. 

Educated in the United States, Dr. Langman graduated with his medical degree from Drexel University College of Medicine in 1977. He then went on to perform his residency in pediatrics and his fellowship in pediatric nephrology at the Children’s Hospital of Philadelphia in 1979 and 1981, respectively. 

With extensive knowledge on the dialysis and transplant processes, the doctor is board-certified in both pediatrics and pediatric nephrology by the American Board of Pediatrics (ABP). The ABP is an independent and nonprofit organization that was founded in 1933. It is one of the 24 certifying boards of the American Board of Medical Specialties. 

Pediatric nephrology involves the diagnosis and treatment of patients with kidney and urinary tract diseases. Pediatric nephrologists diagnose, treat, and manage many disorders affecting the kidney and urinary tract, including kidney failure, high blood pressure, inherited kidney diseases, kidney stones, urinary tract infections, and abnormalities in the urine such as blood and protein. 

A world-renowned researcher and clinician, Dr. Langman has published more than 280 articles, reviews, and chapters in his discipline.

His external professional leadership and service includes: Co-Chair of the Kidney Health Initiative Workgroup for Enteric Hyperoxaluria (2019 – Present); member of the Scholarly Oversight Committee for two nephrology fellows, Vidhi Dalal an Annosh Moin (2019 – Present); Co-Chair of the Hyperoxaluria Advisory Group to FDA, Kidney Health Initiative (2018 – Present); on the Scientific Council of the Rare Bone Disease Alliance (2016 – Present); Panel member and small group leader of common elements of rare kidney diseases, KDIGO (2016 – Present); member of AAP and NKF (2011 – Present); member of the Medicare Clinical Advisory Committee (2004 – Present); and member of the International Conference for Children’s Bone Health (1999 – Present).

Professionally, Dr. Langman is an editorial board member of the European Journal of Pediatrics and the National Osteoporosis Foundation Editorial Board. He is also editor of the Current Osteoporosis Reports, Rare Bone Diseases Section; editor of the Pediatric Nephrology textbook, www.Emedicine.com; section editor, Inherited, Tubular, Metabolic Dis. of the International Pediatric Nephrology Association-Pediatric Nephrology Journal; and scientific advisory board member of the Cystinosis Research Network.

Among his various awards and honors include being a previous Director, Area of Scholar Concentration, Feinberg School of Medicine (2019); Visiting Professor Award at annual Miami Paediatric Nephrology Symposium, Miller School of Medicine, (2019); and Leighton Hill Endowed Lectureship at Baylor College of Medicine, Texas Children’s Hospital, Baylor College of Medicine, and Texas Children’s Hospital (2019).

Recommended Articles

• Understanding Clinical Depression

  Clinical depression is a serious medical illness that negatively affects how an individual feels, thinks, and how he or she acts. Depression varies from mild to severe, and in certain instances the individual can experience temporary episodes of sadness.Clinical depression is also known as major...

• Music Legend Neil Diamond Announces His Diagnosis of Parkinson's Disease

  See the Full List of Celebrities With Parkinson's DiseaseOn Jan. 22, 2018, Neil Diamond announced his shocking and heartbreaking diagnosis of Parkinson's disease, which prompted him to cancel the rest of his 50th anniversary tour in Australia and New Zealand.According to the Parkinson’s...

• Wilms Tumor Facts

  Wilms TumorWilms tumor, also called as nephroblastoma, is a type of cancerous tumor in the kidneys. The name of the disease comes from a German doctor named Max Wilms, who wrote about it in 1899. Children ages 3-4 years old are more likely to develop Wilms tumor.Wilms tumor accounts for around 9 out...

• What Is Renal Ultrasound Used For?

  A renal ultrasound is actually a diagnostic procedure, wherein high-frequency sound waves are transmitted through the body tissues that are inaudible to the human ear. The echoes recorded into videos or images of the internal structures of the body.A wide range of diseases and conditions can be...

• Nephrotic Syndrome in Children: What You Need to Know

  Nephrotic Syndrome in ChildrenNephrotic syndrome in children is not a disease, but rather a group of symptoms that usually indicate kidney damage (particularly glomeruli damage) and proteinuria (high levels of protein in the urine). When there is kidney damage, a protein called albumin, which is...

• What Could Lead to Nephrotic Syndrome?

  IntroductionNephrotic syndrome refers to a group of symptoms that occur when there is something wrong with your kidneys. It can affect people of all ages and is often treatable. Kidney damage may be suspected if an individual shows any of the following symptoms:...